Evaluating Clinical Genome Sequence Analysis by Watson for Genomics-Reference-Cited by-同舟云学术

Evaluating Clinical Genome Sequence Analysis by Watson for Genomics

Published:2018-11-09 Issue: Volume:5 Page:
ISSN:2296-858X
Container-title:Frontiers in Medicine
language:
Short-container-title:Front. Med.

Author:

Itahashi Kota,Kondo Shunsuke,Kubo Takashi,Fujiwara Yutaka,Kato Mamoru,Ichikawa Hitoshi,Koyama Takahiko,Tokumasu Reitaro,Xu Jia,Huettner Claudia S.,Michelini Vanessa V.,Parida Laxmi,Kohno Takashi,Yamamoto Noboru

Publisher

Frontiers Media SA

Subject

General Medicine

Reference23 articles.

1. Molecular prescreening to select patient population in early clinical trials;Rodon;Nat Rev Clin Oncol,2012

2. The landscape of precision cancer medicine clinical trials in the United States;Roper;Cancer Treat Rev,2015

3. Precision medicine for molecularly targeted agents and immunotherapies in early-phase clinical trials;Lopez;Transl Oncogenomics,2015

4. The fuzzy world of precision medicine: deliberations of a precision medicine tumor board;McGraw;Personal. Med.,2017

5. Integrating genomics into clinical pediatric oncology using the molecular tumor board at the memorial sloan kettering cancer center;Ortiz;Pediatric Blood Cancer,2016

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research on biomarkers using innovative artificial intelligence systems in breast cancer;International Journal of Clinical Oncology;2024-08-24

2. Future direction of total neoadjuvant therapy for locally advanced rectal cancer;Nature Reviews Gastroenterology & Hepatology;2024-03-14

3. Evaluation of the Artificial Intelligence Chatbot on Breast Reconstruction and Its Efficacy in Surgical Research: A Case Study;Aesthetic Plastic Surgery;2023-06-14

4. Clinical reporting for personalized cancer genomics requires extensive access to subscription-only literature;Journal of the Medical Library Association;2023-04-21

5. Introducing AI to the molecular tumor board: one direction toward the establishment of precision medicine using large-scale cancer clinical and biological information;Experimental Hematology & Oncology;2022-10-31